Anywhere, from 15% to 28% of cancer diagnoses are misleading. This was the alarming conclusion of an Exploring Diagnostic Accuracy in Cancer survey conducted at late 2012 by the US National Coalition of Health Care and Best Doctors . The traditional methods of cancer diagnostics such as, e.g., mammography (for breast cancer), CT scans, X-ray, ultrasound imaging, MRI and PET (for various other types of cancer) or endoscopy, followed by biopsy of… Read More
Category: blood test for cancer detection, breast cancer, breathanalyzers, cancer biomarker, cancer biomarkers, cancer diagnosis, carbon nanotubes, diagnostic errors, iTBra, mammography overdiagnosis, Medical sensors, Misdiagnosis, Na nose, nano sensors, nanosensors, nanosensors to treat cancer, nanotechnology for cancer diagnostics, nanotube sensor to detect nitic oxide, overdiagnostics, sensor bra, sensors for cancer detection, sensors to detect cancer in the blood, technology for cancer diagnostics, Uncategorized Tags: blood test for cancer detection, breathanalyzers to diagnose cancer, cancer biomarkers, diagnostic errors, iTBra for cancer detection, mammography overdiagnosis, misdiagnosis, nanoparticles, nanosensors to treat cancer, nanotechnology for cancer diagnostic, nanotubes to detect nitric oxide, new methods of cancer diagnostics with nanotechnology, overdiagnosis, overdiagnostics, Reno and wearable sensors, sensor bra, sensors for breast cancer detection, sensors to detect cancer in the blood, technology for cancer diagnostics, traumatic invasive diagnosis, wearable devices, wrong cancer diagnosis
Considering the amount of medications each of us is swallowing during the lifecycle, one would assume that the pharma industry is tremendously flourishing. Indeed, the total volume of the pharmaceutical market was in 2014 worth of 1,057.2 Billion dollars, with the top 15 companies reaching around US$527 billion in revenue. Nevertheless, the modest year-on-year 2.4% growth indicates that the industry needs some revitalizing changes. One of the biggest challenges pharma is facing… Read More
Category: American Society of Consultant Pharmacies, biosensors, clinical trials, diagnostic mistakes, doctros screwed up, graphene biosensor chip, HealthspecPGT, Ingestible Body Temperature Sensor pill, Medical Errors, Medical sensors, medication adherence, medication comliance, medication nonadherence, Moscow Institute of Physics and Technology, nanosensors, Navigenics, non adherence to medications, nonadherence, personalized medication trackers, pharmaceutical industry, ProPublica, Proteus smart pill, SecInCloud, Skype for Business, smart pills, surgical errors, The National Council of Patient Information and Education, University of Chicago Medicine, Virginia Tech, wearable devices, Wu Feng Tags: adherence to medications, advanced analytics and clinical trials, clinical trials improvement, cloud computing and clinical trials, development of biosensors and smart pills, diagnostic errors, diagnostic mistakes, digitalizatoin of pharmaceutical industry, genomic tests, graphene biosensor chip, HQ Inc's CorTemp Ingestible Temperature Sensor pill, medical errors, Medical sensors, medication based on genomic profile, medication nonadherence, medication treatment, nanotubes to analyze biochemical process, Personal Genome Analysis Toolkit, pharmaceutical industry transformation, pharmagenomics, pharnaceutical industry challenges, sensors to analyze reaction on medications, Sequencing in the Cloud, surgical errors, University of Chicago Medicine smart pill, wearable devices
Karen Johnson on Why do patients not adhere to… | |
Karen Johnson on Why do patients not adhere to… | |
RobertTum on Why patients distrust phy… | |
tanyaznamenskaya on Healthcare without care: do pa… | |
Shirley R. Bullock on Healthcare without care: do pa… |
Patients Talk…
Recent Comments